Reviewed Mar 2026 | PubMed sources
Active Market
This comparison can feed directly into US-first legal, provider, and cost workflows.

BPC-157 vs LL-37: Head-to-Head Comparison

BPC-157 is primarily a healing peptide that promotes tissue repair, while LL-37 is a human cathelicidin antimicrobial peptide that serves as a first-line immune defense. LL-37 has direct antimicrobial activity against bacteria, fungi, and viruses, while BPC-157 focuses on structural tissue recovery.

Side-by-Side Comparison

DimensionBPC-157LL-37
Evidence LevelExtensive animal studiesHuman endogenous peptide, well-characterized; clinical studies ongoing
FDA StatusNot approvedNot approved as therapeutic
MechanismAngiogenesis, growth factor modulation, NO pathwayMembrane disruption of pathogens, immune cell recruitment, wound healing
Primary UseTissue repair: gut, tendon, ligamentAntimicrobial defense, biofilm disruption, wound healing
Antimicrobial ActivityNot a primary mechanismBroad-spectrum: antibacterial, antifungal, antiviral
Side EffectsMinimal in animal studiesPotential cytotoxicity at high concentrations, injection site reactions
Evidence Level
BPC-157
Extensive animal studies
LL-37
Human endogenous peptide, well-characterized; clinical studies ongoing
FDA Status
BPC-157
Not approved
LL-37
Not approved as therapeutic
Mechanism
BPC-157
Angiogenesis, growth factor modulation, NO pathway
LL-37
Membrane disruption of pathogens, immune cell recruitment, wound healing
Primary Use
BPC-157
Tissue repair: gut, tendon, ligament
LL-37
Antimicrobial defense, biofilm disruption, wound healing
Antimicrobial Activity
BPC-157
Not a primary mechanism
LL-37
Broad-spectrum: antibacterial, antifungal, antiviral
Side Effects
BPC-157
Minimal in animal studies
LL-37
Potential cytotoxicity at high concentrations, injection site reactions

Peptide Overviews

BPC-157

CPreclinical

BPC-157 is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. Preclinical research suggests it may accelerate wound healing and protect organs from damage.

Healing & RecoveryNot Approved
View full BPC-157 profile →

LL-37

CPreclinical

LL-37 (also written as ll37 or ll-37) is the only cathelicidin antimicrobial peptide found in humans. It plays a crucial role in innate immune defense, wound healing, and inflammation modulation.

Immune SupportNot Approved
View full LL-37 profile →

Supplies for Recovery Protocols

Recovery tools and supplements relevant to this comparison.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Supplies for Both

Common research handling and preparation supplies for injectable peptide workflows.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Recommended Reading

Books covering peptide science, longevity research, and biohacking frameworks.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

BPC-157 vs LL-37: FAQ